TCL Archive Business & Regulatory Report March edition (8 pages) included. By Cancer History Project March 19, 2004
TCL Archive In odd aftermath of FDA Commissioner Mark McClellan’s lecture, NCI Director Andrew von Eschenbach forwards the commissioner’s thank-you note to 3,000 NCI staff. The email blast follows FDA’s return of NCI’s gift to McClellan. By Cancer History Project March 12, 2004
TCL Archive Also in this 8-page issue: NCI informatics project caBIG will “rapidly accelerate” cancer research, von Eschenbach says. By Cancer History Project March 12, 2004
TCL Archive NCI plans 18 percent budget cuts for large R01s, smaller cuts to other research project grants. NCI treatment division director Ellen Feigal accepts position with Translational Genomics Research Institute in Phoeniz, Ariz. By Cancer History Project March 12, 2004
TCL Archive In the cancer centers: San Antonio Cancer Institute gets a new director, funding commitments. By Cancer History Project March 12, 2004
TCL Archive UT Health Science Center dedicates new Children’s Cancer Research Institute. By Cancer History Project March 12, 2004
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. By Cancer History Project March 5, 2004
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
